NOVARTIS PHARMA OBTAINS ADDITIONAL APPROVAL FOR ITS PROPRIETARY IMMUNOSUPPRESSANT NEORAL

A A

Novartis Pharma has obtained additional approval for Neoral (cyclosporine), its proprietary immunosuppressant, from the Ministry of Health, Labor and Welfare.
JCN Network